Free Trial

Globus Medical (GMED) Stock Price, News & Analysis

Globus Medical logo
$54.47 +1.18 (+2.21%)
As of 01:39 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Globus Medical Stock (NYSE:GMED)

Key Stats

Today's Range
$53.30
$54.45
50-Day Range
$51.94
$61.65
52-Week Range
$51.87
$94.93
Volume
587,622 shs
Average Volume
1.44 million shs
Market Capitalization
$7.37 billion
P/E Ratio
40.64
Dividend Yield
N/A
Price Target
$90.09
Consensus Rating
Moderate Buy

Company Overview

Globus Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
99th Percentile Overall Score

GMED MarketRank™: 

Globus Medical scored higher than 99% of companies evaluated by MarketBeat, and ranked 20th out of 939 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Globus Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.62, and is based on 8 buy ratings, 5 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Globus Medical has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Globus Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for Globus Medical are expected to grow by 17.15% in the coming year, from $3.44 to $4.03 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Globus Medical is 40.64, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.74.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Globus Medical is 40.64, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.00.

  • Price to Earnings Growth Ratio

    Globus Medical has a PEG Ratio of 1.58. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Globus Medical has a P/B Ratio of 1.79. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Globus Medical's valuation and earnings.
  • Percentage of Shares Shorted

    3.91% of the float of Globus Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Globus Medical has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Globus Medical has recently decreased by 7.11%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Globus Medical does not currently pay a dividend.

  • Dividend Growth

    Globus Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.91% of the float of Globus Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Globus Medical has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Globus Medical has recently decreased by 7.11%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Globus Medical has a news sentiment score of 0.81. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.06 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 29 news articles for Globus Medical this week, compared to 12 articles on an average week.
  • Search Interest

    9 people have searched for GMED on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Globus Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Globus Medical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    18.51% of the stock of Globus Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    95.16% of the stock of Globus Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Globus Medical's insider trading history.
Receive GMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Globus Medical and its competitors with MarketBeat's FREE daily newsletter.

GMED Stock News Headlines

Globus Medical's (GMED) Hold Rating Reiterated at Needham & Company LLC
Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
Globus Medical Announces New CEO and CFO
See More Headlines

GMED Stock Analysis - Frequently Asked Questions

Globus Medical's stock was trading at $82.71 on January 1st, 2025. Since then, GMED stock has decreased by 34.1% and is now trading at $54.4690.

Globus Medical, Inc. (NYSE:GMED) issued its earnings results on Thursday, May, 8th. The medical device company reported $0.68 EPS for the quarter, missing analysts' consensus estimates of $0.74 by $0.06. The firm's revenue for the quarter was down 1.4% on a year-over-year basis.
Read the conference call transcript
.

Globus Medical's Board of Directors authorized a stock buyback program on Thursday, May 15th 2025, which allows the company to repurchase $500,000,000 in shares, according to EventVestor. This means that the company could repurchase up to 6.3% of its stock through open market purchases. Stock buyback programs are often a sign that the company's management believes its shares are undervalued.

Globus Medical's top institutional investors include Swedbank AB (0.46%), Vaughan Nelson Investment Management L.P. (0.43%), Fort Washington Investment Advisors Inc. OH (0.28%) and Exchange Traded Concepts LLC (0.16%). Insiders that own company stock include David D Davidar, Ann D Rhoads, Leslie V Norwalk, Kelly Huller, Keith W Pfeil, Daniel T Scavilla and Dan Lemaitre.
View institutional ownership trends
.

Shares of GMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Globus Medical investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), CrowdStrike (CRWD), Arista Networks (ANET), Advanced Micro Devices (AMD) and ServiceNow (NOW).

Company Calendar

Last Earnings
5/08/2025
Today
7/25/2025
Next Earnings (Estimated)
8/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Health Care Equipment
Current Symbol
NYSE:GMED
CIK
1237831
Employees
5,300
Year Founded
N/A

Price Target and Rating

High Price Target
$115.00
Low Price Target
$68.00
Potential Upside/Downside
+69.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.62
Research Coverage
13 Analysts

Profitability

EPS (Trailing Twelve Months)
$1.34
Trailing P/E Ratio
39.75
Forward P/E Ratio
15.48
P/E Growth
1.58
Net Income
$102.98 million
Net Margins
7.39%
Pretax Margin
9.28%
Return on Equity
10.52%
Return on Assets
8.56%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.45
Quick Ratio
2.72

Sales & Book Value

Annual Sales
$2.51 billion
Price / Sales
2.87
Cash Flow
$6.56 per share
Price / Cash Flow
8.12
Book Value
$30.40 per share
Price / Book
1.75

Miscellaneous

Outstanding Shares
135,379,000
Free Float
110,320,000
Market Cap
$7.21 billion
Optionable
Optionable
Beta
1.19

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NYSE:GMED) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners